← Back
Data updated: Mar 29, 2026
AVET LIFESCIENCES
Infectious DiseaseOncologyMetabolic
Generics
AVET LIFESCIENCES is a generic drug manufacturer focused on Infectious Disease, Oncology, Metabolic.
1977
Since
35
Drugs
-
Trials
256
Approved (2yr)
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
DOXYCYCLINE HYCLATE 2026-02-19
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
ZOLEDRONIC ACID 2026-02-05
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 50%
5 drugs
Oncology 20%
2 drugs
Metabolic 10%
1 drugs
Dermatology 10%
1 drugs
Immunology 10%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Pfizer big-pharma
Oncology, Infectious Disease, Dermatology, Immunology
Merck big-pharma
Oncology, Infectious Disease, Immunology, Metabolic
Johnson & Johnson big-pharma
Oncology, Immunology, Infectious Disease, Metabolic
Sanofi big-pharma
Metabolic, Oncology, Infectious Disease, Immunology
Eli Lilly big-pharma
Metabolic, Oncology, Immunology, Dermatology
Active (20)
NEOSTIGMINE METHYLSULFATE METOCLOPRAMIDE RIZATRIPTAN BENZOATE PHENYLEPHRINE HYDROCHLORIDE CIDOFOVIR IBANDRONATE SODIUM TRANEXAMIC ACID ACARBOSE ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE ONDANSETRON HYDROCHLORIDE FOSCARNET SODIUM COLISTIMETHATE SODIUM PROPOFOL RIFAMPIN ETOMIDATE PENTAMIDINE ISETHIONATE AMPHOTERICIN B VANCOMYCIN HYDROCHLORIDE BICNU DOXYCYCLINE HYCLATE
Discontinued (14)
Company Info
- First Approval
- 1977-03-07
- Latest
- 2026-02-19
- Applications
- 40